News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Shapiro David
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/28/2020 |
3
| Shapiro David (Director) has filed a Form 3 on Galecto Inc. |
09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/03/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Sold 2,000 shares
@ $86.28, valued at
$172.6k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
04/16/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Sold 2,000 shares
@ $95, valued at
$190k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
04/03/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 482 shares
@ $111.5, valued at
$53.7k
Sold 562 shares
@ $115.01, valued at
$64.6k
|
|
03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 3,300 shares
@ $0 Granted 5,300 options to buy
@ $110.8, valued at
$587.2k
|
|
01/04/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Sold 474 shares
@ $97.48, valued at
$46.2k
|
|
01/03/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 736 shares
@ $100.79, valued at
$74.2k
Sold 2,000 shares
@ $98.28, valued at
$196.6k
Sold 699 shares
@ $97.45, valued at
$68.1k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
12/19/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Sold 2,000 shares
@ $106.62, valued at
$213.2k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
12/06/2018 |
4
| Shapiro David (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC.
Txns:
| Granted 46,500 options to buy
@ $1.01, valued at
$47k
Granted 30,000 options to buy
@ $1.01, valued at
$30.3k
|
|
12/06/2018 |
3
| Shapiro David (Director) has filed a Form 3 on ORGANOVO HOLDINGS, INC. |
11/02/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Sold 2,000 shares
@ $96.32, valued at
$192.6k
Exercised 2,000 options to buy
@ $21.5, valued at
$43k
|
|
10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/07/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Sold 4,917 shares
@ $111.428, valued at
$547.9k
|
|
02/22/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns:
| Granted 2,900 shares
@ $0 Granted 4,400 options to buy
@ $58.74, valued at
$258.5k
|
|
10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/03/2017 |
4
| Shapiro David (CMO and EVP - Development) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns:
| Granted 6,000 shares
@ $0 Granted 10,000 options to buy
@ $107.18, valued at
$1.1M
|
|
01/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|